SBI Securities
BLTE icon

SBI Securities’s Belite Bio BLTE Stock Holding History

SBI Securities’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19K Buy
112
+90
+409% +$14.6K ﹤0.01% 1572
2026
Q2 		$3.39K Hold
22
– – ﹤0.01% 2349
2026
Q1 		$3.51K Sell
22
-28
-56% -$4.71K ﹤0.01% 2186
2025
Q4 		$8K Sell
50
-2
-4% -$237 ﹤0.01% 1814
2025
Q3 		$3.85K Hold
52
– – ﹤0.01% 2151
2025
Q2 		$3K Sell
52
-52
-50% -$3.17K ﹤0.01% 2225
2025
Q1 		$6.89K Buy
104
+90
+643% +$5.42K ﹤0.01% 1761
2024
Q4 		$883 Buy
+14
New +$923 ﹤0.01% 2669

Other funds holding BLTE

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
West Paces Advisors
West Paces Advisors Atlanta, Georgia $586M AUM 14.12% 1-Year Est. Return

SBI Securities's BLTE Position: Q3 2026 in Review

SBI Securities increased its Belite Bio (BLTE) stake by 409% in Q3 2026, buying an estimated $14.6K and bringing the position to 112 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1572.

SBI Securities first reported a position in BLTE in Q4 2024 and has held it in 8 quarters since. 5 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • SBI Securities held 112 shares of Belite Bio worth $19K as of Q3 2026.
  • SBI Securities bought 90 Belite Bio shares in Q3 2026, an estimated $14.6K.
  • Belite Bio made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #1572 holding.
  • SBI Securities first reported a position in Belite Bio in Q4 2024 and has held it in 8 quarters since.
  • 5 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.